As of June 8, 2025, Zogenix Inc (ZGNX) reports a EV/EBITDA of -7.22.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Zogenix Inc's EV/EBITDA to Peers
To better understand Zogenix Inc's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Zogenix Inc (ZGNX) | -7.22 |
| Eli Lilly and Co (LLY) | 46.67 |
| Catalent Inc (CTLT) | 45.03 |
| SNDL Inc (SNDL) | 35.30 |
| Zoetis Inc (ZTS) | 20.76 |
| Royalty Pharma PLC (RPRX) | 13.43 |
Compared to its competitors, Zogenix Inc's EV/EBITDA is among the lowest compared to peers, which may indicate undervaluation or market concerns about future performance.